These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21137046)

  • 1. Proteomics of bacterial pathogens: Pseudomonas aeruginosa infections in cystic fibrosis - a case study.
    Hare NJ; Cordwell SJ
    Proteomics Clin Appl; 2010 Feb; 4(2):228-48. PubMed ID: 21137046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa.
    Williams HD; Zlosnik JE; Ryall B
    Adv Microb Physiol; 2007; 52():1-71. PubMed ID: 17027370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis.
    Lamont IL; Konings AF; Reid DW
    Biometals; 2009 Feb; 22(1):53-60. PubMed ID: 19130260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis.
    Ramsey DM; Wozniak DJ
    Mol Microbiol; 2005 Apr; 56(2):309-22. PubMed ID: 15813726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung.
    Hogardt M; Heesemann J
    Int J Med Microbiol; 2010 Dec; 300(8):557-62. PubMed ID: 20943439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alginate production by the mucoid Pseudomonas aeruginosa associated with cystic fibrosis.
    Gill JF; Deretic V; Chakrabarty AM
    Microbiol Sci; 1987 Oct; 4(10):296-9. PubMed ID: 3155272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment.
    Finnan S; Morrissey JP; O'Gara F; Boyd EF
    J Clin Microbiol; 2004 Dec; 42(12):5783-92. PubMed ID: 15583313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections.
    Beckmann C; Brittnacher M; Ernst R; Mayer-Hamblett N; Miller SI; Burns JL
    Infect Immun; 2005 Jan; 73(1):444-52. PubMed ID: 15618183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.
    Ojeniyi B
    APMIS Suppl; 1994; 46():1-44. PubMed ID: 7811529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics of hosts and pathogens in cystic fibrosis.
    Kamath KS; Kumar SS; Kaur J; Venkatakrishnan V; Paulsen IT; Nevalainen H; Molloy MP
    Proteomics Clin Appl; 2015 Feb; 9(1-2):134-46. PubMed ID: 25418359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antimicrobial sensitivity patterns as markers of Pseudomonas aeruginosa cross-infection at a cystic fibrosis clinic.
    Williams T
    Br J Biomed Sci; 1997 Sep; 54(3):181-5. PubMed ID: 9499595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Pseudomonas aeruginosa use intercellular signalling to build biofilm communities?
    Kirisits MJ; Parsek MR
    Cell Microbiol; 2006 Dec; 8(12):1841-9. PubMed ID: 17026480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies.
    Kukavica-Ibrulj I; Levesque RC
    Lab Anim; 2008 Oct; 42(4):389-412. PubMed ID: 18782827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Høiby N; Ciofu O; Bjarnsholt T
    Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis and the pseudomonads.
    Wright KC
    Br J Biomed Sci; 1996 Jun; 53(2):140-5. PubMed ID: 8757691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.